Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters

Frontiers in Molecular Biosciences(2023)10.3389/fmolb.2023.1133123Source: DataRank Database

G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters is a research paper published in Frontiers in Molecular Biosciences (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

refseq

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.73)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Shalu Sharma ORCID,Zaigham Abbas Rizvi ORCID,Dipanjali Sinha,Divya Gupta ORCID,Mercy Rophina ORCID

Live enrichment

PubMed:37006620 PMC:PMC10061221 OpenAlex:https://openalex.org/W4327618916

DBT/Wellcome Trust India Alliance

Grant: IA/S/18/2/504021

Wellcome Trust

Grant: unidentified

unidentified

FWCI

0.73

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fmolb.2023.1133123/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fmolb.2023.1133123/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fmolb.2023.1133123/full

journalhttps://doi.org/10.3389/fmolb.2023.1133123

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37006620

Fields of Study

DNA and Nucleic Acid ChemistryAdvanced biosensing and bioanalysis techniquesRNA Interference and Gene Delivery0301 basic medicine03 medical and health sciences

Keywords

Viral replicationVirologyNucleic acidChlorpromazineDrugRNABiologyTranscription (linguistics)IdoxuridineCoronavirus disease 2019 (COVID-19)VirusPharmacologyMedicineGeneticsGeneInfectious disease (medical specialty)Fda-approved DrugsRna G-quadruplexConserved MotifG-Quadruplex Binding DrugsHamster Model Of Covid-19QH301-705.5Molecular BiosciencesBiology (General)

Sustainable Development Goals

SDG 0: Good health and well-being

G4-binding drugs, chlorpromazine and prochlorperazine, repurposed against COVID-19 infection in hamsters

FAIR Checklist

Authors (17)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)